SAS vs. SAS vs. Phoenix [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-12 13:01 (707 d 09:09 ago) – Posting: # 20788
Views: 5,466

Hi to all victims of the partial replicate with incomplete data,

following extensive off-list discussions with PharmCat (who is working on a [image] Julia-package; see here and there) I checked again what we got with the FDA’s covariance structure, Satterthwaite’s df (PE, 90% CI).
Not the slightest idea how I arrived at the results given above. Sorry for the confusion caused.
In all cases simplifying the covariance structure (in SAS-lingo FA0(1) instead of the FA0(2) in the guidance): Convergence without warning.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,743 posts in 4,546 threads, 1,543 registered users;
online 22 (0 registered, 22 guests [including 2 identified bots]).
Forum time: Tuesday 23:11 CEST (Europe/Vienna)

Sometimes the key to an answer is found
in the way you formulate the question.    David Brin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5